Bioqual (OTCMKTS:BIOQ) Issues Quarterly Earnings Results

Bioqual (OTCMKTS:BIOQ) posted its quarterly earnings results on Tuesday. The company reported ($1.36) earnings per share (EPS) for the quarter, Zacks reports. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.

Bioqual Stock Down 3.8 %

Shares of Bioqual stock opened at $62.50 on Wednesday. The firm’s 50-day moving average price is $66.46 and its two-hundred day moving average price is $68.45. Bioqual has a 12-month low of $62.50 and a 12-month high of $80.00. The company has a market capitalization of $55.63 million, a price-to-earnings ratio of -50.81 and a beta of -0.33.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.